ONCY
Oncolytics Biotech
ONCY
ONCY
36 hedge funds and large institutions have $822K invested in Oncolytics Biotech in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 2 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
75% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 8
Holders
36
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$12.9K | |
| 2 | +$8.09K | |
| 3 | +$6.33K | |
| 4 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
+$4.96K |
| 5 |
Stifel Financial
St. Louis,
Missouri
|
+$4.08K |
Top Sellers
| 1 | -$101K | |
| 2 | -$70K | |
| 3 | -$34K | |
| 4 |
TSS
Two Sigma Securities
New York
|
-$21K |
| 5 |
Two Sigma Advisers
New York
|
-$11K |